Risk-benefit balance assessment of SSRI antidepressant use during pregnancy and lactation based on best available evidence – an update

References

• Organisation WH. Depression. 2018. [cited 2019 May]. Available from: https://www.who.int/en/news-room/fact-sheets/detail/depression.
   Google Scholar
• Bellantuono C, Migliarese G, Gentile S. Serotonin reuptake inhibitors in pregnancy and the risk of major malformations: a systematic review. Hum Psychopharmacol. 2007;22(3):121–128.
   PubMed Web of Science ®Google Scholar
• Gaynes BN, Gavin N, Meltzer-Brody S, et al. Perinatal depression: prevalence, screening accuracy, and screening outcomes. Evid Rep Technol Assess (Full Rep). 2005;119:1–8.
   Google Scholar
• O’Connor E, Rossom RC, Henninger M, et al. Primary care screening for and treatment of depression in pregnant and postpartum women: evidence report and systematic review for the US preventive services task force. JAMA. 2016;315(4):388–406.
   PubMed Web of Science ®Google Scholar
• Excellence NIfHaC. Antenatal and postnatal mental health: clinical management and service guidance. 2014. [cited 2019 May]. Available from: https://www.nice.org.uk/guidance/cg192.
   Google Scholar
• Reilly N, Kingston D, Loxton D, et al. A narrative review of studies addressing the clinical effectiveness of perinatal depression screening programs. Women Birth. 2019;S1871-5192(18)30164-1.
   Google Scholar
• Hanley GE, Mintzes B. Patterns of psychotropic medicine use in pregnancy in the United States from 2006 to 2011 among women with private insurance. BMC Pregnancy Childbirth. 2014;14:242.
   PubMed Web of Science ®Google Scholar
• Zoega H, Kieler H, Norgaard M, et al. Use of SSRI and SNRI antidepressants during pregnancy: a population-based study from Denmark, Iceland, Norway and Sweden. PLoS One. 2015;10(12):e0144474.
   PubMed Web of Science ®Google Scholar
• Weisskopf E, Fischer CJ, Bickle Graz M, et al. Risk-benefit balance assessment of SSRI antidepressant use during pregnancy and lactation based on best available evidence. Expert Opin Drug Saf. 2015;14(3):413–427.
   PubMed Web of Science ®Google Scholar
• Kawaura K, Honda S, Soeda F, et al. [Novel antidepressant-like action of drugs possessing GIRK channel blocking action in rats]. Yakugaku Zasshi. 2010;130(5):699–705.
   PubMed Web of Science ®Google Scholar
• Schaffir J. Consequences of antepartum depression. Clin Obstet Gynecol. 2018;61(3):533–543.
   PubMed Web of Science ®Google Scholar
• Becker M, Weinberger T, Chandy A, et al. Depression during pregnancy and postpartum. Curr Psychiatry Rep. 2016;18(3):32.
   PubMed Web of Science ®Google Scholar
• Gentile S. Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of birth defects. Acta Psychiatr Scand. 2011;123(4):266–275.
   PubMed Web of Science ®Google Scholar
• Barr JA, Beck CT. Infanticide secrets: qualitative study on postpartum depression. Cana Family Physician Med Famille Canadien. 2008;54(12):1716–7 e5.
   PubMed Web of Science ®Google Scholar
• Kauppi A, Kumpulainen K, Vanamo T, et al. Maternal depression and filicide-case study of ten mothers. Arch Women’s Mental Health. 2008;11(3):201–206.
   PubMed Web of Science ®Google Scholar
• Howard LM, Flach C, Mehay A, et al. The prevalence of suicidal ideation identified by the Edinburgh Postnatal Depression Scale in postpartum women in primary care: findings from the RESPOND trial. BMC Pregnancy Childbirth. 2011;11:57.
   PubMed Web of Science ®Google Scholar
• Lindahl V, Pearson JL, Colpe L. Prevalence of suicidality during pregnancy and the postpartum. Arch Women’s Mental Health. 2005;8(2):77–87.
   PubMed Web of Science ®Google Scholar
• Pope CJ, Xie B, Sharma V, et al. A prospective study of thoughts of self-harm and suicidal ideation during the postpartum period in women with mood disorders. Arch Women’s Mental Health. 2013;16(6):483–488.
   PubMed Web of Science ®Google Scholar
• Pajulo M, Savonlahti E, Sourander A, et al. Antenatal depression, substance dependency and social support. J Affect Disord. 2001;65(1):9–17.
   PubMed Web of Science ®Google Scholar
• Connelly CD, Hazen AL, Baker-Ericzen MJ, et al. Is screening for depression in the perinatal period enough? The co-occurrence of depression, substance abuse, and intimate partner violence in culturally diverse pregnant women. J Womens Health (Larchmt). 2013;22(10):844–852.
   PubMed Web of Science ®Google Scholar
• Flynn HA, Chermack ST. Prenatal alcohol use: the role of lifetime problems with alcohol, drugs, depression, and violence. J Stud Alcohol Drugs. 2008;69(4):500–509.
   PubMed Web of Science ®Google Scholar
• Alberque C, Bianchi-Demicheli F, Andreoli A, et al. Management of severe antepartum depression: an update. Rev Med Suisse. 2008;4(144):392,4, 6–7.
   Google Scholar
• Hu R, Li Y, Zhang Z, et al. Antenatal depressive symptoms and the risk of preeclampsia or operative deliveries: a meta-analysis. PLoS One. 2015;10(3):e0119018.
   PubMed Web of Science ®Google Scholar
• Szegda K, Markenson G, Bertone-Johnson ER, et al. Depression during pregnancy: a risk factor for adverse neonatal outcomes? A critical review of the literature. J Matern Fetal Neonatal Med. 2014;27(9):960–967.
   PubMed Web of Science ®Google Scholar
• Jarde A, Morais M, Kingston D, et al. Neonatal outcomes in women with untreated antenatal depression compared with women without depression: a systematic review and meta-analysis. JAMA Psychiatry. 2016;73(8):826–837.
   PubMed Web of Science ®Google Scholar
• Sugiura-Ogasawara M, Furukawa TA, Nakano Y, et al. Depression as a potential causal factor in subsequent miscarriage in recurrent spontaneous aborters. Hum Reprod. 2002;17(10):2580–2584.
   PubMed Web of Science ®Google Scholar
• Grigoriadis S, VonderPorten EH, Mamisashvili L, et al. The effect of prenatal antidepressant exposure on neonatal adaptation: a systematic review and meta-analysis. J Clin Psychiatry. 2013;74(4):e309–20.
   PubMed Web of Science ®Google Scholar
• Figueiredo B, Canario C, Field T. Breastfeeding is negatively affected by prenatal depression and reduces postpartum depression. Psychol Med. 2014;44(5):927–936.
   PubMed Web of Science ®Google Scholar
• Madigan S, Oatley H, Racine N, et al. A meta-analysis of maternal prenatal depression and anxiety on child socioemotional development. J Am Acad Child Adolesc Psychiatry. 2018;57(9):645–57 e8.
   PubMed Web of Science ®Google Scholar
• Faleschini S, Rifas-Shiman SL, Tiemeier H, et al. Associations of prenatal and postnatal maternal depressive symptoms with offspring cognition and behavior in mid-childhood: a prospective cohort study. Int J Environ Res Public Health. 2019;16:6.
   Web of Science ®Google Scholar
• Pearson RM, Evans J, Kounali D, et al. Maternal depression during pregnancy and the postnatal period: risks and possible mechanisms for offspring depression at age 18 years. JAMA Psychiatry. 2013;70(12):1312–1319.
   PubMed Web of Science ®Google Scholar
• Robertson E, Grace S, Wallington T, et al. Antenatal risk factors for postpartum depression: a synthesis of recent literature. Gen Hosp Psychiatry. 2004;26(4):289–295.
   PubMed Web of Science ®Google Scholar
• Field T. Postpartum depression effects on early interactions, parenting, and safety practices: a review. Infant Behav Dev. 2010;33(1):1–6.
   PubMed Web of Science ®Google Scholar
• Choi KW, Sikkema KJ, Vythilingum B, et al. Maternal childhood trauma, postpartum depression, and infant outcomes: Avoidant affective processing as a potential mechanism. J Affect Disord. 2017;211:107–115.
   PubMed Web of Science ®Google Scholar
• Deave T, Heron J, Evans J, et al. The impact of maternal depression in pregnancy on early child development. BJOG. 2008;115(8):1043–1051.
   PubMed Web of Science ®Google Scholar
• Austin MP, Hadzi-Pavlovic D, Leader L, et al. Maternal trait anxiety, depression and life event stress in pregnancy: relationships with infant temperament. Early Hum Dev. 2005;81(2):183–190.
   PubMed Web of Science ®Google Scholar
• Luoma I, Tamminen T, Kaukonen P, et al. Longitudinal study of maternal depressive symptoms and child well-being. J Am Acad Child Adolesc Psychiatry. 2001;40(12):1367–1374.
   PubMed Web of Science ®Google Scholar
• Barker ED, Jaffee SR, Uher R, et al. The contribution of prenatal and postnatal maternal anxiety and depression to child maladjustment. Depress Anxiety. 2011;28(8):696–702.
   PubMed Web of Science ®Google Scholar
• Bolton JM, Dahl M, Sareen J, et al. A population-based study of the use of selective serotonin reuptake inhibitors before and after introduction of generic equivalents. Can J Psychiatry Revue Canadienne De Psychiatrie. 2012;57(4):223–229.
   PubMed Web of Science ®Google Scholar
• Bonache S, Mata A, Ramos MD, et al. Sperm gene expression profile is related to pregnancy rate after insemination and is predictive of low fecundity in normozoospermic men. Hum Reprod. 2012;27(6):1556–1567.
   PubMed Web of Science ®Google Scholar
• NICE. Depression in adults: recognition and management. April 2018. [cited 2019 May]. Available from: https://www.nice.org.uk/guidance/cg90/chapter/1-Guidance.
   Google Scholar
• AAP. Treating major depressive disorder. 2010. [cited 2019 May]. Available from: http://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/mdd-guide.pdf.
   Google Scholar
• Fournier JC, DeRubeis RJ, Hollon SD, et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA. 2010;303(1):47–53.
   PubMed Web of Science ®Google Scholar
• Kirsch I, Deacon BJ, Huedo-Medina TB, et al. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med. 2008;5(2):e45.
   PubMed Web of Science ®Google Scholar
• Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018;391(10128):1357–1366.
   PubMed Web of Science ®Google Scholar
• O’Connor E, Senger CA, Henninger ML, et al. Interventions to prevent perinatal depression: evidence report and systematic review for the US preventive services task force. JAMA. 2019;321(6):588–601.
   PubMed Web of Science ®Google Scholar
• Zemestani M, Fazeli Nikoo Z. Effectiveness of mindfulness-based cognitive therapy for comorbid depression and anxiety in pregnancy: a randomized controlled trial. Arch Women’s Mental Health. 2019.
   PubMedGoogle Scholar
• Dennis CL, Interventions DT. (other than pharmacological, psychosocial or psychological) for treating antenatal depression. Cochrane Database Syst Rev. 2013;7:CD006795.
   Google Scholar
• Field T, Deeds O, Diego M, et al. Benefits of combining massage therapy with group interpersonal psychotherapy in prenatally depressed women. J Bodyw Mov Ther. 2009;13(4):297–303.
   PubMedGoogle Scholar
• Manber R, Schnyer RN, Lyell D, et al. Acupuncture for depression during pregnancy: a randomized controlled trial. Obstet Gynecol. 2010;115(3):511–520.
   PubMed Web of Science ®Google Scholar
• Freeman MP, Davis M, Sinha P, et al. Omega-3 fatty acids and supportive psychotherapy for perinatal depression: a randomized placebo-controlled study. J Affect Disord. 2008;110(1–2):142–148.
   PubMed Web of Science ®Google Scholar
• Wirz-Justice A, Bader A, Frisch U, et al. A randomized, double-blind, placebo-controlled study of light therapy for antepartum depression. J Clin Psychiatry. 2011;72(7):986–993.
   PubMed Web of Science ®Google Scholar
• Muzik M, Hamilton SE, Lisa Rosenblum K, et al. Mindfulness yoga during pregnancy for psychiatrically at-risk women: preliminary results from a pilot feasibility study. Complement Ther Clin Pract. 2012;18(4):235–240.
   PubMedGoogle Scholar
• Guardino CM, Dunkel Schetter C, Bower JE, et al. Randomised controlled pilot trial of mindfulness training for stress reduction during pregnancy. Psychol Health. 2014;29(3):334–349.
   PubMed Web of Science ®Google Scholar
• Dimidjian S, Goodman SH, Felder JN, et al. Staying well during pregnancy and the postpartum: A pilot randomized trial of mindfulness-based cognitive therapy for the prevention of depressive relapse/recurrence. J Consult Clin Psychol. 2016;84(2):134–145.
   PubMed Web of Science ®Google Scholar
• Molyneaux E, Telesia LA, Henshaw C, et al. Antidepressants for preventing postnatal depression. Cochrane Database Syst Rev. 2018;4:CD004363.
   PubMedGoogle Scholar
• Panchaud A, Weisskopf E, Winterfeld U, et al. [Pharmacokinetic alterations in pregnancy and use of therapeutic drug monitoring]. Therapie. 2014;69(3):223–234.
   PubMed Web of Science ®Google Scholar
• Heikkinen T, Ekblad U, Kero P, et al. Citalopram in pregnancy and lactation. Clin Pharmacol Ther. 2002;72(2):184–191.
   PubMed Web of Science ®Google Scholar
• Freeman MP, Nolan PE Jr., Davis MF, et al. Pharmacokinetics of sertraline across pregnancy and postpartum. J Clin Psychopharmacol. 2008;28(6):646–653.
   PubMed Web of Science ®Google Scholar
• Heikkinen T, Ekblad U, Palo P, et al. Pharmacokinetics of fluoxetine and norfluoxetine in pregnancy and lactation. Clin Pharmacol Ther. 2003;73(4):330–337.
   PubMed Web of Science ®Google Scholar
• Sit DK, Perel JM, Helsel JC, et al. Changes in antidepressant metabolism and dosing across pregnancy and early postpartum. J Clin Psychiatry. 2008;69(4):652–658.
   PubMed Web of Science ®Google Scholar
• Hendrick V, Stowe ZN, Altshuler LL, et al. Placental passage of antidepressant medications. Am J Psychiatry. 2003;160(5):993–996.
   PubMed Web of Science ®Google Scholar
• Frayne J, Nguyen T, Allen S, et al. Motherhood and mental illness–part 2–management and medications. Aust Fam Physician. 2009;38(9):688–692.
   PubMedGoogle Scholar
• Hemels ME, Einarson A, Koren G, et al. Antidepressant use during pregnancy and the rates of spontaneous abortions: a meta-analysis. Ann Pharmacother. 2005;39(5):803–809.
   PubMed Web of Science ®Google Scholar
• Nikfar S, Rahimi R, Hendoiee N, et al. Increasing the risk of spontaneous abortion and major malformations in newborns following use of serotonin reuptake inhibitors during pregnancy: A systematic review and updated meta-analysis. Daru. 2012;20(1):75.
   PubMedGoogle Scholar
• Andersen JT, Andersen NL, Horwitz H, et al. Exposure to selective serotonin reuptake inhibitors in early pregnancy and the risk of miscarriage. Obstet Gynecol. 2014;124(4):655–661.
   PubMed Web of Science ®Google Scholar
• Johansen RL, Mortensen LH, Andersen AM, et al. Maternal use of selective serotonin reuptake inhibitors and risk of miscarriage - assessing potential biases. Paediatr Perinat Epidemiol. 2015;29(1):72–81.
   PubMed Web of Science ®Google Scholar
• Kjaersgaard MI, Parner ET, Vestergaard M, et al. Prenatal antidepressant exposure and risk of spontaneous abortion - a population-based study. PLoS One. 2013;8(8):e72095.
   PubMed Web of Science ®Google Scholar
• Zhang TN, Gao SY, Shen ZQ, et al. Use of selective serotonin-reuptake inhibitors in the first trimester and risk of cardiovascular-related malformations: a meta-analysis of cohort studies. Sci Rep. 2017;7:43085.
   PubMed Web of Science ®Google Scholar
• Bar-Oz B, Einarson T, Einarson A, et al. Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors. Clin Ther. 2007;29(5):918–926.
   PubMed Web of Science ®Google Scholar
• Wurst KE, Poole C, Ephross SA, et al. First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: a meta-analysis of epidemiological studies. Birth Defects Res Part A, Clin Mol Teratol. 2010;88(3):159–170.
   PubMedGoogle Scholar
• Jimenez-Solem E, Andersen JT, Petersen M, et al. Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study. BMJ Open. 2012;2:3.
   Web of Science ®Google Scholar
• Berard A, Zhao JP, Sheehy O. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort. BMJ Open. 2017;7(1):e013372.
   PubMed Web of Science ®Google Scholar
• Riggin L, Frankel Z, Moretti M, et al. The fetal safety of fluoxetine: a systematic review and meta-analysis. J Obstetrics Gynaecol Can JOGC. 2013;35(4):362–369.
   PubMedGoogle Scholar
• Jordan S, Morris JK, Davies GI, et al. Selective Serotonin Reuptake Inhibitor (SSRI) antidepressants in pregnancy and congenital anomalies: analysis of linked databases in Wales, Norway and Funen, Denmark. PLoS One. 2016;11(12):e0165122.
   PubMed Web of Science ®Google Scholar
• Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39(12):1890–1900.
   PubMed Web of Science ®Google Scholar
• Byatt N, Deligiannidis KM, Freeman MP. Antidepressant use in pregnancy: a critical review focused on risks and controversies. Acta Psychiatr Scand. 2013;127(2):94–114.
   PubMed Web of Science ®Google Scholar
• Yazdy MM, Mitchell AA, Louik C, et al. Use of selective serotonin-reuptake inhibitors during pregnancy and the risk of clubfoot. Epidemiology. 2014;25(6):859–865.
   PubMed Web of Science ®Google Scholar
• Nielsen SW, Ljungdalh PM, Nielsen J, et al. Maternal use of selective serotonin reuptake inhibitors during pregnancy is associated with Hirschsprung’s disease in newborns - a nationwide cohort study. Orphanet J Rare Dis. 2017;12(1):116.
   PubMedGoogle Scholar
• Reefhuis J, Devine O, Friedman JM, et al. Specific SSRIs and birth defects: Bayesian analysis to interpret new data in the context of previous reports. Bmj. 2015;351:h3190.
   PubMed Web of Science ®Google Scholar
• Guan HB, Wei Y, Wang LL, et al. Prenatal selective serotonin reuptake inhibitor use and associated risk for gestational hypertension and preeclampsia: a meta-analysis of cohort studies. J Womens Health (Larchmt). 2018;27(6):791–800.
   PubMed Web of Science ®Google Scholar
• Uguz F. Is there any association between use of antidepressants and preeclampsia or gestational hypertension?: A Systematic Review of current studies. J Clin Psychopharmacol. 2017;37(1):72–77.
   PubMed Web of Science ®Google Scholar
• Palmsten K, Setoguchi S, Margulis AV, et al. Elevated risk of preeclampsia in pregnant women with depression: depression or antidepressants? Am J Epidemiol. 2012;175(10):988–997.
   PubMed Web of Science ®Google Scholar
• Palmsten K, Huybrechts KF, Michels KB, et al. Antidepressant use and risk for preeclampsia. Epidemiology. 2013;24(5):682–691.
   PubMed Web of Science ®Google Scholar
• Avalos LA, Chen H, Li DK. Antidepressant medication use, depression, and the risk of preeclampsia. CNS Spectr. 2015;20(1):39–47.
   PubMed Web of Science ®Google Scholar
• Bruning AH, Heller HM, Kieviet N, et al. Antidepressants during pregnancy and postpartum hemorrhage: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2015;189:38–47.
   PubMed Web of Science ®Google Scholar
• Oberg AS, Hernandez-Diaz S, Palmsten K, et al. Patterns of recurrence of postpartum hemorrhage in a large population-based cohort. Am J Obstet Gynecol. 2014;210(3):229 e1–8.
   Web of Science ®Google Scholar
• Lupattelli A, Spigset O, Koren G, et al. Risk of vaginal bleeding and postpartum hemorrhage after use of antidepressants in pregnancy: a study from the Norwegian mother and child cohort study. J Clin Psychopharmacol. 2014;34(1):143–148.
   PubMed Web of Science ®Google Scholar
• Salkeld E, Ferris LE, Juurlink DN. The risk of postpartum hemorrhage with selective serotonin reuptake inhibitors and other antidepressants. J Clin Psychopharmacol. 2008;28(2):230–234.
   PubMed Web of Science ®Google Scholar
• Eke AC, Saccone G, Berghella V. Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis. BJOG. 2016;123(12):1900–1907.
   PubMed Web of Science ®Google Scholar
• Malm H, Sourander A, Gissler M, et al. Pregnancy complications following prenatal exposure to ssris or maternal psychiatric disorders: results from population-based national register data. Am J Psychiatry. 2015;172(12):1224–1232.
   PubMed Web of Science ®Google Scholar
• Zhao X, Liu Q, Cao S, et al. A meta-analysis of selective serotonin reuptake inhibitors (SSRIs) use during prenatal depression and risk of low birth weight and small for gestational age. J Affect Disord. 2018;241:563–570.
   PubMed Web of Science ®Google Scholar
• Nezvalova-Henriksen K, Spigset O, Brandlistuen RE, et al. Effect of prenatal selective serotonin reuptake inhibitor (SSRI) exposure on birthweight and gestational age: a sibling-controlled cohort study. Int J Epidemiol. 2016;45(6):2018–2029.
   PubMed Web of Science ®Google Scholar
• Sujan AC, Rickert ME, Oberg AS, et al. Associations of maternal antidepressant use during the first trimester of pregnancy with preterm birth, small for gestational age, autism spectrum disorder, and attention-deficit/hyperactivity disorder in offspring. Jama. 2017;317(15):1553–1562.
   PubMed Web of Science ®Google Scholar
• Ross LE, Grigoriadis S, Mamisashvili L, et al. Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis. JAMA Psychiatry. 2013;70(4):436–443.
   PubMed Web of Science ®Google Scholar
• Kivisto J, Lehto SM, Halonen K, et al. Maternal use of selective serotonin reuptake inhibitors and lengthening of the umbilical cord: indirect evidence of increased foetal activity-a retrospective cohort study. PLoS One. 2016;11(4):e0154628.
   PubMed Web of Science ®Google Scholar
• Norby U, Forsberg L, Wide K, et al. Neonatal morbidity after maternal use of antidepressant drugs during pregnancy. Pediatrics. 2016;138:5.
   Web of Science ®Google Scholar
• Oberlander TF, Warburton W, Misri S, et al. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry. 2006;63(8):898–906.
   PubMed Web of Science ®Google Scholar
• Levinson-Castiel R, Merlob P, Linder N, et al. Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Arch Pediatr Adolesc Med. 2006;160(2):173–176.
   PubMedGoogle Scholar
• Leibovitch L, Rymer-Haskel N, Schushan-Eisen I, et al. Short-term neonatal outcome among term infants after in utero exposure to serotonin reuptake inhibitors. Neonatology. 2013;104(1):65–70.
   PubMed Web of Science ®Google Scholar
• Moses-Kolko EL, Bogen D, Perel J, et al. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA. 2005;293(19):2372–2383.
   PubMed Web of Science ®Google Scholar
• Laine K, Heikkinen T, Ekblad U, et al. Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. Arch Gen Psychiatry. 2003;60(7):720–726.
   PubMed Web of Science ®Google Scholar
• Rampono J, Simmer K, Ilett KF, et al. Placental transfer of SSRI and SNRI antidepressants and effects on the neonate. Pharmacopsychiatry. 2009;42(3):95–100.
   PubMed Web of Science ®Google Scholar
• Grigoriadis S, Vonderporten EH, Mamisashvili L, et al. Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis. Bmj. 2014;348:f6932.
   PubMed Web of Science ®Google Scholar
• Chambers CD, Hernandez-Diaz S, Van Marter LJ, et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med. 2006;354(6):579–587.
   PubMed Web of Science ®Google Scholar
• Kallen B, Olausson PO. Maternal use of selective serotonin re-uptake inhibitors and persistent pulmonary hypertension of the newborn. Pharmacoepidemiol Drug Saf. 2008;17(8):801–806.
   PubMed Web of Science ®Google Scholar
• Andrade SE, McPhillips H, Loren D, et al. Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn. Pharmacoepidemiol Drug Saf. 2009;18(3):246–252.
   PubMed Web of Science ®Google Scholar
• Wilson KL, Zelig CM, Harvey JP, et al. Persistent pulmonary hypertension of the newborn is associated with mode of delivery and not with maternal use of selective serotonin reuptake inhibitors. Am J Perinatol. 2011;28(1):19–24.
   PubMed Web of Science ®Google Scholar
• Kieler H, Artama M, Engeland A, et al. Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries. Bmj. 2012;344:d8012.
   PubMed Web of Science ®Google Scholar
• Bergner CL, Smolinsky AN, Hart PC, et al. Mouse models for studying depression-like states and antidepressant drugs. Methods Mol Biol. 2010;602:267–282.
   PubMedGoogle Scholar
• Berard A, Sheehy O, Zhao JP, et al. SSRI and SNRI use during pregnancy and the risk of persistent pulmonary hypertension of the newborn. Br J Clin Pharmacol. 2017;83(5):1126–1133.
   PubMed Web of Science ®Google Scholar
• Huybrechts KF, Bateman BT, Palmsten K, et al. Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn. Jama. 2015;313(21):2142–2151.
   PubMed Web of Science ®Google Scholar
• Hooper CW, Delaney C, Streeter T, et al. Selective serotonin reuptake inhibitor exposure constricts the mouse ductus arteriosus in utero. Am J Physiol Heart Circ Physiol. 2016;311(3):H572–81.
   PubMed Web of Science ®Google Scholar
• Gentile S, Galbally M. Prenatal exposure to antidepressant medications and neurodevelopmental outcomes: a systematic review. J Affect Disord. 2011;128(1–2):1–9.
   PubMed Web of Science ®Google Scholar
• Kott J, Brummelte S. Trick or treat? Evaluating contributing factors and sex-differences for developmental effects of maternal depression and its treatment. Horm Behav. 2019;111:31–45.
   PubMed Web of Science ®Google Scholar
• Lugo-Candelas C, Cha J, Hong S, et al. Associations between brain structure and connectivity in infants and exposure to selective serotonin reuptake inhibitors during pregnancy. JAMA Pediatr. 2018;172(6):525–533.
   PubMed Web of Science ®Google Scholar
• Jha SC, Meltzer-Brody S, Steiner RJ, et al. Antenatal depression, treatment with selective serotonin reuptake inhibitors, and neonatal brain structure: A propensity-matched cohort study. Psychiatry Res Neuroimaging. 2016;253:43–53.
   PubMed Web of Science ®Google Scholar
• Podrebarac SK, Duerden EG, Chau V, et al. Antenatal exposure to antidepressants is associated with altered brain development in very preterm-born neonates. Neuroscience. 2017;342:252–262.
   PubMed Web of Science ®Google Scholar
• Rotem-Kohavi N, Williams LJ, Virji-Babul N, et al. Alterations in resting-state networks following in utero selective serotonin reuptake inhibitor exposure in the neonatal brain. Biol Psychiatry Cogn Neurosci Neuroimaging. 2019;4(1):39–49.
   PubMedGoogle Scholar
• Videman M, Tokariev A, Saikkonen H, et al. Newborn brain function is affected by fetal exposure to maternal serotonin reuptake inhibitors. Cereb Cortex. 2017;27(6):3208–3216.
   PubMed Web of Science ®Google Scholar
• Halvorsen A, Hesel B, Ostergaard SD, et al. In utero exposure to selective serotonin reuptake inhibitors and development of mental disorders: a systematic review and meta-analysis. Acta Psychiatr Scand. 2019.
   PubMed Web of Science ®Google Scholar
• Yamamoto-Sasaki M, Yoshida S, Takeuchi M, et al. Association between antidepressant use during pregnancy and autism spectrum disorder in children: a retrospective cohort study based on Japanese claims data. Matern Health Neonatol Perinatol. 2019;5:1.
   PubMedGoogle Scholar
• El Marroun H, White TJ, Fernandez G, et al. Prenatal exposure to selective serotonin reuptake inhibitors and non-verbal cognitive functioning in childhood. J Psychopharmacol. 2017;31(3):346–355.
   PubMed Web of Science ®Google Scholar
• Eriksen HL, Kesmodel US, Pedersen LH, et al. No association between prenatal exposure to psychotropics and intelligence at age five. Acta Obstet Gynecol Scand. 2015;94(5):501–507.
   PubMed Web of Science ®Google Scholar
• Johnson KC, Smith AK, Stowe ZN, et al. Preschool outcomes following prenatal serotonin reuptake inhibitor exposure: differences in language and behavior, but not cognitive function. J Clin Psychiatry. 2016;77(2):e176–82.
   PubMed Web of Science ®Google Scholar
• Hermansen TK, Roysamb E, Augusti EM, et al. Behavior and inhibitory control in children with prenatal exposure to antidepressants and medically untreated depression. Psychopharmacology (Berl). 2016;233(8):1523–1535.
   PubMed Web of Science ®Google Scholar
• Viktorin A, Uher R, Kolevzon A, et al. Association of antidepressant medication use during pregnancy with intellectual disability in offspring. JAMA Psychiatry. 2017;74(10):1031–1038.
   PubMed Web of Science ®Google Scholar
• Liu X, Agerbo E, Ingstrup KG, et al. Antidepressant use during pregnancy and psychiatric disorders in offspring: Danish nationwide register based cohort study. Bmj. 2017;358:j3668.
   PubMedGoogle Scholar
• Brown AS, Gyllenberg D, Malm H, et al. Association of selective serotonin reuptake inhibitor exposure during pregnancy with speech, scholastic, and motor disorders in offspring. JAMA Psychiatry. 2016;73(11):1163–1170.
   PubMed Web of Science ®Google Scholar
• Skurtveit S, Selmer R, Roth C, et al. Prenatal exposure to antidepressants and language competence at age three: results from a large population-based pregnancy cohort in Norway. BJOG. 2014;121(13):1621–1631.
   PubMed Web of Science ®Google Scholar
• Lupattelli A, Wood M, Ystrom E, et al. Effect of time-dependent selective serotonin reuptake inhibitor antidepressants during pregnancy on behavioral, emotional, and social development in preschool-aged children. J Am Acad Child Adolesc Psychiatry. 2018;57(3):200–208.
   PubMed Web of Science ®Google Scholar
• Hanley GE, Brain U, Oberlander TF. Prenatal exposure to serotonin reuptake inhibitor antidepressants and childhood behavior. Pediatr Res. 2015;78(2):174–180.
   PubMed Web of Science ®Google Scholar
• Malm H, Brown AS, Gissler M, et al. Gestational exposure to selective serotonin reuptake inhibitors and offspring psychiatric disorders: a national register-based study. J Am Acad Child Adolesc Psychiatry. 2016;55(5):359–366.
   PubMed Web of Science ®Google Scholar
• Grove K, Lewis AJ, Galbally M. Prenatal antidepressant exposure and child motor development: a meta-analysis. Pediatrics. 2018;142:1.
   Web of Science ®Google Scholar
• Byrd RA, Markham JK. Developmental toxicology studies of fluoxetine hydrochloride administered orally to rats and rabbits. Fundam Appl Toxicol. 1994;22(4):511–518.
   PubMedGoogle Scholar
• Gorman JR, Kao K, Chambers CD. Breastfeeding among women exposed to antidepressants during pregnancy. J Hum Lact. 2012;28(2):181–188.
   PubMed Web of Science ®Google Scholar
• Den Besten-Bertholee D, van der Meer DH, Ter Horst PGJ. Quality of lactation studies investigating antidepressants. Breastfeed Med. 2019;14(6):359–365.
   PubMed Web of Science ®Google Scholar
• Rubin ET, Lee A, Ito S. When breastfeeding mothers need CNS-acting drugs. Can J Clin Pharmacol. 2004;11(2):e257–66.
   PubMedGoogle Scholar
• Wettermark B, Zoega H, Furu K, et al. The Nordic prescription databases as a resource for pharmacoepidemiological research–a literature review. Pharmacoepidemiol Drug Saf. 2013;22(7):691–699.
   PubMed Web of Science ®Google Scholar
• Palmsten K, Huybrechts KF, Mogun H, et al. Harnessing the medicaid analytic eXtract (MAX) to evaluate medications in pregnancy: design considerations. PLoS One. 2013;8(6):e67405.
   PubMed Web of Science ®Google Scholar
• Hernandez-Diaz S, Oberg AS. Are epidemiological approaches suitable to study risk/preventive factors for human birth defects? Curr Epidemiol Rep. 2015;2(1):31–36.
   PubMedGoogle Scholar
• Huybrechts KF, Bateman BT, Hernandez-Diaz S. Use of real-world evidence from healthcare utilization data to evaluate drug safety during pregnancy. Pharmacoepidemiol Drug Saf. 2019.
   Web of Science ®Google Scholar
• Palmsten K, Hernandez-Diaz S. Can nonrandomized studies on the safety of antidepressants during pregnancy convincingly beat confounding, chance, and prior beliefs? Epidemiology. 2012;23(5):686–688.
   PubMed Web of Science ®Google Scholar
• Coverdale JH, McCullough LB, Chervenak FA. The ethics of randomized placebo-controlled trials of antidepressants with pregnant women: a systematic review. Obstet Gynecol. 2008;112(6):1361–1368.
   PubMed Web of Science ®Google Scholar
• Monk C, Spicer J, Champagne FA. Linking prenatal maternal adversity to developmental outcomes in infants: the role of epigenetic pathways. Dev Psychopathol. 2012;24(4):1361–1376.
   PubMed Web of Science ®Google Scholar
• Nestler EJ. Epigenetic mechanisms of depression. JAMA Psychiatry. 2014;71(4):454–456.
   PubMed Web of Science ®Google Scholar